Werewolf Therapeutics logo

Werewolf Therapeutics

HOWL | NASDAQ
Chart Builder DCF Calculator
$0.99
+$0.01 (+0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
$0.00 (+0.08%)
After-hours: Nov 16, 2026, 7:30 PM ET
+0.99%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.5
+1.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #594/1021 (Top 58%)

Key Statistics

Market Data

Market Cap $48.15M
1D Range
0.95 1.00
52W Range
0.31 1.10

Valuation (TTM)

PE -1.74
PB 7.12
EV/EBITDA -0.41

Valuation (NTM)

Forward PE N/A
Forward PEG 0.04
Price Target $1.00
Loading financial charts...

Profile

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the...

Sector Healthcare
Industry Biotechnology
Employees 39
IPO Date Apr 30, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 16, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$1.00
Upside
+1.01%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.